Dianalitics
Tennant Company
TNC · v1 · 2026-09-29
hourglass
Loading…
Preparing the latest DD data, styles and content.
59NeutralDD: Sep 29, 2026Analyst: 59
paidPrice at analysis date
USD 68.2 (29/09/2026)
domainMkt cap
$1.16B
pie_chartShares
17.05M
candlestick_chart52W
$60.17-$91.93
trending_downShort interest
8.01%
MEDIUMNYSEConsumer Discretionary
Verdict: Neutral - value screen with margin-recovery proof still pending

Tennant qualifies for today's FATTORIALE/VALUE screen because the stock trades at roughly 13.9x forward earnings and below 1.0x forward sales after an ERP-driven margin reset. The independent DD is more cautious than the screen: demand, backlog and robotics momentum are real, but Q2 profitability fell sharply and the base fair value is only modestly above the verified T-1 close.

DIANALITICS RESEARCH INDEX
Score /100 - updated 2026-09-29
59
Tennant Company
Industrial machinery, cleaning equipment and AMR robotics
Value rerating setup, but not yet a quality rerating: the market is discounting margin execution, working-capital conversion and EMEA/APAC demand softness.
Fin. strength
12
/20 pts
EBITDA/FCF
8
/15 pts
Debt/leverage
9
/15 pts
Stage/business
12
/15 pts
Catalysts
6
/10 pts
Reg. risk
6
/8 pts
Risk/reward
4
/7 pts
Management
3
/5 pts
Sector/macro
2
/3 pts
Compliance
1
/2 pts
VALUEERP RECOVERYROBOTICS GROWTHMARGIN RESET
Base case fair value - EV/EBITDA bridge
Fair value base case
USD 73.0
Range: USD 56.0-USD 91.0
Price at analysis date: USD 68.2 (29/09/2026)
Base upside/downside: +7%

Peer median EV/EBITDA is above 10x, but the selected 9.0x multiple is derived from a discount for observed margin compression, FCF weakness and net leverage at the upper end of management's 1x-2x target. Implied core multiple equals the nominal 9.0x; after AMR and reserve items, the effective FV is about 9.6x FY2026E EBITDA. Cross-check: analyst average $87.75 is 20% above this DD fair value, explained by this report's heavier ERP/FCF haircut. Sensitivity: +/-2x EBITDA multiple moves FV by about +/-$19/sh, so the thesis is highly sensitive to margin recovery. Not investment advice.

ComponentAssumptionUSD/share
Core equipment operating EV$162.5M FY2026E adjusted EBITDA midpoint x 9.0x EV/EBITDA / 17.05M shares+85.78
Net debt bridge($1.48B EV - $1.16B market cap) = approx. $320M net debt / 17.05M shares-18.77
AMR robotics option35% probability x $250M 2028 AMR revenue target x 1.0x EV/Sales / 17.05M shares+5.13
ERP / working-capital reserve-$45M execution reserve for delayed ERP savings, receivables conversion and EMEA pricing pressure / 17.05M shares-2.64
Repurchase accretion$60M deployed at $63 average price in 2026 program / 17.05M shares, value credited only for already visible share-count reduction+3.52
FV base caseExplicit sum of components above: 85.78 - 18.77 + 5.13 - 2.64 + 3.52 = $73.02, rounded to $73.00$73.00
Bull
$88-$91
Probability: 30%
ERP recovery normalizes gross margin, AMR growth remains near 35%-40%, and FY2027 EBITDA confidence supports 10.5x FY2026E EBITDA.
Base
$73
Probability: 45%
Revenue guidance is met, but margin recovery remains gradual; valuation holds around 9.0x EBITDA with a small robotics option value.
Bear
$55-$58
Probability: 25%
ERP savings slip again, EMEA/APAC softness continues, FCF stays negative and the market values the business closer to 7.5x EBITDA.
Methodology: Peer median EV/EBITDA is above 10x, but the selected 9.0x multiple is derived from a discount for observed margin compression, FCF weakness and net leverage at the upper end of management's 1x-2x target. Implied core multiple equals the nominal 9.0x; after AMR and reserve items, the effective FV is about 9.6x FY2026E EBITDA. Cross-check: analyst average $87.75 is 20% above this DD fair value, explained by this report's heavier ERP/FCF haircut. Sensitivity: +/-2x EBITDA multiple moves FV by about +/-$19/sh, so the thesis is highly sensitive to margin recovery. Not investment advice. Not investment advice.
check_circle
Screening result - FATTORIALE / VALUE
Selection gate: current verified close $68.21, market cap about $1.16B, forward P/E about 13.9x, forward P/S about 0.88x, shares outstanding down 5.5% year over year and 2026 revenue guidance raised to $1.270-$1.310B. The VALUE tag is a screening criterion only; the fair value below is derived independently from peer multiples, guidance, net debt and execution reserves.
TNC was not present as a covered ticker in the DD history.
Capital Structure - Short Interest - Buyback & Dilution
Short Interest
8.0%
1.317M shares short as of Sep 15, 2026, equal to about 8.0% of float and 7.0 days to cover. Moderate, not a squeeze-led thesis.
Share dilution (1Y)
-5.5%
Shares outstanding fell to 17.05M, down 5.48% year over year. Repurchases are a real value support while FCF recovers.
Buyback
Active
StockAnalysis shows a 5.48% buyback yield and 7.29% shareholder yield. Capital return is positive, but leverage is already near 2.0x.
Short Interest - context
TNC - 8.0%
8.0%

Governance/litigation check: targeted searches did not surface an active securities class action, short-seller report or SEC investigation for Tennant in the last 12 months. Form 4 snippets did not show insider sales above the $500K threshold; routine filings remain a monitor item rather than a thesis driver.

$Financial analysis - FY
Q2 2026 net sales
$324.0M
+1.7% YoY
Q2 adjusted EBITDA
$35.3M
-30.8% YoY
FY26 revenue guide
$1.27-$1.31B
Raised Aug 2026
Net leverage
2.0x
Upper end of target
ItemFY2023FY2024FY2025FY2026E / TTMGuidance / note
Net sales~$1.24B$1.287B$1.204B$1.270-$1.310BFY2026 guide raised
Adjusted EBITDA~$179M$208.8M$167.4M$155-$170MFY2026 guide lowered
GAAP net incomeN/D$83.7M$43.8M$42-$48M est.From EPS guide and 17.05M shares
Free cash flowPositivePositivePressured by ERP-$3.1M TTMWorking-capital conversion is the key test
Adjusted diluted EPSN/D$6.57$4.57$3.80-$4.45Lowered Aug 2026
Quarterly dynamics - last 5 quarters
MetricQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Revenue ($M)318.6315.8291.6297.9324.0
Gross margin %42.1%N/DN/DN/D39.5%
Net income ($M)20.220.8-4.40.27.6
Cash EOP ($M)N/DN/DN/DN/D76.9
FY26 sales guide confidence
High
Margin recovery proof
Pending
FCF conversion
Weak
account_tree

Business model - installed base plus robotics optionality

Durable niche, temporary execution discount
Tennant designs and services commercial and industrial cleaning equipment, detergents, parts and autonomous mobile robot floor-care systems. The core installed base gives service and aftermarket stickiness, while robotics can improve the growth profile if the Brain Corp enterprise agreement and AMR ramp convert to recurring fleet demand.

Americas Q2 organic +1.4% recovering Price realization and Latin America strength offset North America production and fulfillment constraints. EMEA Q2 organic -2.8% margin pressure Southern Europe, Benelux and export-market softness create pricing and mix pressure. APAC / AMR APAC -10.6%; AMR +37% mixed APAC demand is weak, but autonomous mobile robot sales are a meaningful option on future growth.

gavel

Legal, regulatory and risk analysis

ERP execution
High
North America ERP disruption still affects gross margin, receivables and inventory conversion.
Margin compression
High
Q2 adjusted EBITDA margin fell 510 bps year over year to 10.9%.
Orders and backlog
Positive
Orders grew 6.6% and backlog reached $127M, supporting the higher sales guide.
Robotics adoption
Positive
AMR sales grew about 37% year over year and management still points to a $250M 2028 target.
Leverage
Medium
Net leverage is 2.0x, the upper end of the stated target range, limiting aggressive buybacks if EBITDA misses.
Short interest
Moderate
8% of float short can add volatility but is not high enough to define the thesis.
Governance / litigation
Low
No active securities class action, SEC investigation or short-seller report surfaced in current searches.
Analyst target gap
Medium
Consensus sits well above this DD's FV, but much of that gap depends on margin recovery that is not yet proven.
article

SWOT analysis

Strengths
  • +Global installed base, service network and 4,500-employee operating footprint.
  • +Orders and backlog improved despite profitability pressure.
  • +Repurchases reduced shares outstanding materially year over year.
Weaknesses
  • −ERP disruption has lasted longer than a clean quality thesis would allow.
  • −Trailing free cash flow is negative and leverage is near the upper target band.
  • −Q2 gross margin and adjusted EPS both declined sharply.
Opportunities
  • →AMR robotics can shift the narrative from cyclical equipment to technology-enabled fleet productivity.
  • →A Q3/Q4 margin recovery could close part of the discount to analyst targets.
  • →Current valuation is below higher-quality industrial equipment peers.
Threats
  • !EMEA/APAC volume softness persists into 2027.
  • !ERP savings arrive slower than guidance assumes.
  • !Buybacks slow if cash conversion does not rebound.
article

Summary by assessment area

Valuation - Fair
  • Forward multiples screen inexpensive, but base FV is only 7% above spot.
  • The consensus target requires stronger margin normalization than this DD assumes.
Execution - Watch
  • ERP, receivables and gross margin are the real catalysts.
  • Revenue guidance strength is not enough without EBITDA recovery.
Optionality - Robotics
  • AMR growth creates upside if enterprise adoption scales.
  • The option is capped in the base case until reported revenue proves durability.
Sources & Disclaimer

Sources: Tennant Q2 2026 results filed Aug 5, 2026; Tennant Q2 earnings-call transcript; Tennant FY2025 results release; StockAnalysis statistics and forecast pages; MarketBeat forecast and short-interest pages; StockScan and Equibles Sep 28, 2026 close pages; Investing.com historical price page; ChartExchange historical table. Market data - last verified close 2026-09-28: TNC $68.21 (StockScan and Equibles), cross-check ChartExchange $68.27; market cap ~$1.16B; enterprise value ~$1.48B; shares outstanding 17.05M; 52W range $60.17-$91.93; short interest 1.317M shares / 8.01% float / 7.0 days to cover as of Sep 15, 2026. This document is for informational purposes only and does not constitute financial or investment advice.